Spain · AEMPS CIMA

EMEND 125 MG POLVO PARA SUSPENSION ORAL

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
103262011
Form
POLVO PARA SUSPENSIÓN ORAL
Composition / generic term
aprepitant
Source strength
125 mg
Authorisation holder
Merck Sharp & Dohme B.V.
Marketed in source snapshot
No

Source-listed ingredients

  • APREPITANT — 125 mg

These values do not establish equivalence or a dose recommendation.

Packages

  • EMEND 125 MG POLVO PARA SUSPENSION ORAL Caja con 1 sobre que contiene polvo para suspensión oral

Source and coverage

Open AEMPS CIMA

Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Spain records →